Improvement of Body Weight and Nutritional Status in Gastric Cancer Patients Enhances the Benefit of Nivolumab Therapy

por Ikoma, Tatsuki, Matsumoto, Toshihiko, Kurioka, Yusuke, Takatani, Masahiro, Nagai, Hiroki, Matsumoto, Yusuke, Satake, Hironaga, Yasui, Hisateru
Publicado 2022

Author Correction: Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab

por Matsumoto, Toshihiko, Ikoma, Tatsuki, Yamamura, Shogo, Miura, Kou, Tsuduki, Takao, Watanabe, Takanori, Nagai, Hiroki, Takatani, Masahiro, Yasui, Hisateru
Publicado 2023

Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan

por Ikoma, Tatsuki, Shimokawa, Mototsugu, Kotaka, Masahito, Matsumoto, Toshihiko, Nagai, Hiroki, Boku, Shogen, Shibata, Nobuhiro, Yasui, Hisateru, Satake, Hironaga
Publicado 2021

Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab

por Matsumoto, Toshihiko, Ikoma, Tatsuki, Yamamura, Shogo, Miura, Kou, Tsuduki, Takao, Watanabe, Takanori, Nagai, Hiroki, Takatani, Masahiro, Yasui, Hisateru
Publicado 2023

Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multice...

por Nakasya, Akio, Hagiwara, Yuya, Ikoma, Tatsuki, Kurioka, Yusuke, Matsumoto, Toshihiko, Yamamoto, Yoshiyuki, Tsuduki, Takao, Kajiwara, Takeshi, Moriwaki, Toshikazu, Nishina, Tomohiro, Yamashita, Natsumi, Hyodo, Ichinosuke
Publicado 2022

Risk factors and efficacy outcomes of early-onset severe neutropenia due to paclitaxel or nanoparticle albumin-bound paclitaxel combined with ramucirumab in advanced gastric cancer...

por Hagiwara, Yuya, Nakasya, Akio, Matsumoto, Toshihiko, Ikoma, Tatsuki, Yamamoto, Yoshiyuki, Kurioka, Yusuke, Tsuduki, Takao, Kajiwara, Takeshi, Nishina, Tomohiro, Yamashita, Natsumi, Moriwaki, Toshikazu, Hyodo, Ichinosuke
Publicado 2022

Real-World Data of Trastuzumab Deruxtecan for Advanced Gastric Cancer: A Multi-Institutional Retrospective Study

por Matsumoto, Toshihiko, Yamamura, Shogo, Ikoma, Tatsuki, Kurioka, Yusuke, Doi, Keitaro, Boku, Shogen, Shibata, Nobuhiro, Nagai, Hiroki, Shimada, Takanobu, Tsuduki, Takao, Tsumura, Takehiko, Takatani, Masahiro, Yasui, Hisateru, Satake, Hironaga
Publicado 2022

A Retrospective Study Investigating the Safety and Efficacy of Nanoliposomal Irinotecan in Elderly Patients with Unresectable Pancreatic Cancer

por Ikoma, Tatsuki, Matsumoto, Toshihiko, Boku, Shogen, Yasuda, Tomoyo, Masuda, Masataka, Ito, Takashi, Nakamaru, Koh, Yamaki, So, Nakayama, Shinji, Hashimoto, Daisuke, Yamamoto, Tomohisa, Shibata, Nobuhiro, Ikeura, Tsukasa, Naganuma, Makoto, Satoi, Sohei, Kurata, Takayasu
Publicado 2023

Real-World Data of Trifluridine/Tipiracil for Patients With Advanced Gastric Cancer: A Multi-Institutional Retrospective Study

por Matsumoto, Toshihiko, Yamamura, Shogo, Ikoma, Tatsuki, Kurioka, Yusuke, Doi, Keitaro, Yasuda, Tomoyo, Boku, Shogen, Kawai, Takashi, Shibata, Nobuhiro, Nagai, Hiroki, Tsuduki, Takao, Shimada, Takanobu, Matsumoto, Yusuke, Tsumura, Takehiko, Takatani, Masahiro, Yasui, Hisateru, Satake, Hironaga
Publicado 2022